| Author | Ray-Coquard, I. | dc.contributor.author |
| Author | Pautier, P. | dc.contributor.author |
| Author | Pignata, S. | dc.contributor.author |
| Author | Perol, D. | dc.contributor.author |
| Author | Gonzalez-Martin, A. | dc.contributor.author |
| Author | Berger, R. | dc.contributor.author |
| Author | Fujiwara, K. | dc.contributor.author |
| Author | Vergote, I. | dc.contributor.author |
| Author | Colombo, N. | dc.contributor.author |
| Author | Maenpaa, J. | dc.contributor.author |
| Author | Selle, F. | dc.contributor.author |
| Author | Sehouli, J. | dc.contributor.author |
| Author | Lorusso, D. | dc.contributor.author |
| Author | Alia, E. M. Guerra | dc.contributor.author |
| Author | Reinthaller, A. | dc.contributor.author |
| Author | Nagao, S. | dc.contributor.author |
| Author | Lefeuvre-Plesse, C. | dc.contributor.author |
| Author | Canzler, U. | dc.contributor.author |
| Author | Scambia, G. | dc.contributor.author |
| Author | Lortholary, A. | dc.contributor.author |
| Author | Marme, F. | dc.contributor.author |
| Author | Combe, P. | dc.contributor.author |
| Author | de Gregorio, N. | dc.contributor.author |
| Author | Rodrigues, M. | dc.contributor.author |
| Author | Buderath, P. | dc.contributor.author |
| Author | Dubot, C. | dc.contributor.author |
| Author | Burges, A. | dc.contributor.author |
| Author | You, B. | dc.contributor.author |
| Author | Pujade-Lauraine, E. | dc.contributor.author |
| Author | Harter, P. | dc.contributor.author |
| Author | PAOLA-Investigators | dc.contributor.author |
| Date of accession | 2020-01-24T05:30:00Z | dc.date.accessioned |
| Available in OPARU since | 2020-01-24T05:30:00Z | dc.date.available |
| Date of first publication | 2019 | dc.date.issued |
| Language | en | dc.language.iso |
| Publisher | Universität Ulm | dc.publisher |
| Keyword | TRIAL GROUPS REQUIREMENTS | dc.subject |
| Keyword | DOUBLE-BLIND | dc.subject |
| Keyword | EUROPEAN NETWORK | dc.subject |
| Keyword | ACADEMIC GROUPS | dc.subject |
| Keyword | THERAPY | dc.subject |
| Keyword | CARCINOMA | dc.subject |
| Keyword | SURVIVAL | dc.subject |
| Keyword | OUTCOMES | dc.subject |
| Keyword | WOMEN | dc.subject |
| Dewey Decimal Group | DDC 610 / Medicine & health | dc.subject.ddc |
| Title | Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer | dc.title |
| Resource type | Wissenschaftlicher Artikel | dc.type |
| Institution | UKU. Klinik für Frauenheilkunde und Geburtshilfe | uulm.affiliationSpecific |
| DCMI Type | Text | uulm.typeDCMI |
| Category | Publikationsnachweise | uulm.category |
| DOI (external) | 10.1056/NEJMoa1911361 | dc.identifier.doiExternal |
| Source - Title of source | New England Journal of Medicine | source.title |
| Source - Place of publication | Massachusetts Medical Society | source.publisher |
| Source - Volume | 381 | source.volume |
| Source - Issue | 25 | source.issue |
| Source - Year | 2019 | source.year |
| Source - From page | 2416 | source.fromPage |
| Source - To page | 2428 | source.toPage |
| Source - ISSN | 0028-4793 | source.identifier.issn |
| Source - eISSN | 1533-4406 | source.identifier.eissn |
| Community | Universitätsklinikum Ulm | uulm.community |
| WoS | 000505222400006 | uulm.identifier.wos |
| Bibliography | uulm | uulm.bibliographie |
